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Body Mass Index Has a Linear Relationship with
Cerebrospinal Fluid Pressure
John P. Berdahl,1,2 David Fleischman,2,3 Jana Zaydlarova,4 Sandra Stinnett,5
R. Rand Allingham,5,6 and Michael P. Fautsch4,6
PURPOSE. To examine the relationship between body mass
index (BMI) and cerebrospinal fluid pressure (CSFP), as low
BMI and low CSFP have recently been described as risk factors
for primary open-angle glaucoma (POAG).
METHODS. This was a retrospective review of the electronic
medical records of patients who had CSFP measured by lumbar
puncture and data to calculate BMI at the Mayo Clinic (Roch-
ester, MN). Exclusion criteria included diagnoses, surgical pro-
cedures and medications known to affect CSFP. Mean CSFP for
each unit BMI was calculated. The probabilities were two-
tailed, and the  level was set at P  0.05. Patients with
documented BMI, CSFP, and intraocular pressure (IOP) were
analyzed for the relationship between IOP and BMI.
RESULTS. A total of 4235 patients, primarily of Caucasian de-
scent, met the entry criteria. Median BMI was 26 and the mean
CSFP was 10.9  2.6 mm Hg. The increase in CSFP with
increasing BMI was linear with an r2  0.20 (P  0.001). CSFP
increased by 37.7% from BMI 18 (8.6  2.1 mm Hg) to BMI 39
(14.1  2.5 mm Hg). The r2 (0.21) of the model of BMI and sex
was similar to the r2 of a BMI-only model (0.20). There was no
relation between IOP and BMI within a subgroup of the study
population (r 2  0.005; P  0.14).
CONCLUSIONS. CSFP has a positive, linear relationship with BMI.
IOP is not influenced by BMI. If CSFP influences the risk for
POAG, then individuals with a lower BMI may have an in-
creased risk for developing POAG. Similarly, a higher BMI may
be protective. (Invest Ophthalmol Vis Sci. 2012;53:
1422–1427) DOI:10.1167/iovs.11-8220
Well-recognized risk factors for primary open-angle glau-coma (POAG) include age, race, positive family history,
and elevated intraocular pressure. More recently, cerebrospi-
nal fluid pressure (CSFP) has been suggested as a risk factor for
POAG. Studies have shown that individuals with POAG or
normal-tension glaucoma (NTG) have lower CSFP when com-
pared with the normal population.1–4 It is postulated that
increasing translaminar pressure, the difference between intra-
ocular pressure (IOP) and the CSFP, damages the optic nerve
and contributes to glaucomatous optic neuropathy. It has also
been postulated that higher CSFP, which reduces the translami-
nar pressure, may reduce the risk for glaucoma.
Body mass index (BMI) has been reported to be a risk factor
for POAG.5–11 However, the nature of this relationship is un-
clear. Newman-Casey et al.5 found that obesity in females of a
mostly Caucasian population (86.7% Caucasian, 4.3% Black,
5.6% Latinos, and 2.5% Asian Americans) was associated with a
greater risk of developing POAG5 while the Tajimi Eye Study
(Japan) found no association between glaucoma and BMI.6,7
On the other hand, Asrani et al.8 reported that lower BMI was
associated with increased risk for NTG. This study was pre-
ceded by the Barbados Eye Study, in which Leske et al.9 found
that decreased BMI was associated with greater risk for glau-
coma in the Barbados population of African ancestry. Recently,
in two separate studies, Pasquale10 and Ramdas11 found that
increased BMI in females reduces risk of developing glaucoma.
In addition, Ren et al.12 found a statistically significant corre-
lation between elevated CSFP levels and higher BMI in a small
cohort (n  39). They conclude that low BMI may be a
potential risk factor for NTG. Overall, these latter studies sug-
gest that increased BMI is protective for glaucoma, whereas
decreased BMI may be associated with greater risk.
The purpose of this study was to investigate the relationship
between BMI and CSFP, while also determining if a relationship
exists between IOP and BMI.
METHODS
Institutional Review Board approval was obtained from the Mayo
Clinic (Rochester, MN). The study adhered to the tenets of Decla-
ration of Helsinki and was in compliance with the Health Insurance
Portability and Accountability Act (HIPAA). A search of the elec-
tronic medical records database at Mayo Clinic identified all patients
who underwent a diagnostic lumbar puncture (LP; CPT code:
62,270) between December 1, 1996, and December 31, 2009. A
present diagnosis and medical history of each patient who under-
went LP was retrieved.
A standard LP technique was used in all patients. Each patient was
placed in the lateral decubitus position and either the L3 to L4 or L4 to
L5 interspace was identified and anesthetized. A 3.5-in., 20-gauge
spinal needle with a three-way stopcock was inserted into the sub-
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arachnoid space. A 550-mm manometer was attached to the stopcock,
and the column of CSF fluid was allowed to equilibrate. The patient
was asked to remain still and not to speak. The meniscus of the CSF
fluid was read and reported in millimeters of water. This value was
converted to millimeters of mercury to allow comparison with IOP and
data analysis (1 mm Hg  13.6 mm H2O).
All electronic information was de-identified according to routine
procedure at the Mayo Clinic. Information from specific patients
was given a unique, randomly generated identifier and entered into
a database. Patients with medical conditions or those taking medi-
cations known to alter CSFP were excluded, as were those who had
sustained head trauma. The files were manually reviewed and un-
derwent screening against conditions that are known to or theoret-
ically could cause alterations in CSFP. Subjects were excluded from
analysis if a diagnosis of a disorder or condition that could affect
CSFP was documented in the electronic medical record. Patients
had undergone a neurosurgical procedure or had more than one LP
were excluded. Analysis was confined to patients with CSFP mea-
surements within a range of 4.4 to 18.4 mm Hg (60 –250 mm H2O)
since data outside that range was likely to be unreliable or the result
of a pathophysiologic process affecting the CSFP.13 Data from all
patients meeting the inclusion criteria with recorded height and
weight at the time of LP were used for the analysis. BMI for each
patient was calculated manually [BMI  (weight in kilograms)/
(height in meters)2] and rounded to the nearest whole number.
BMIs less than 10 and greater than 50 were excluded, as these
values were felt to be the result of data entry errors.
The definition of “overweight” by the BMI criterion varies until
adulthood. For this reason, we limited the analysis to include only
adults. In this manner, we were able to use a BMI value 30 as our
definition of obesity. We used the WHO criterion of 20 years as the age
of adulthood.14
Subjects who met the inclusion criteria were grouped by BMI.
Mean CSFP and SD were calculated for each BMI group. A Student’s
t-test comparison of each mean CSFP to pressure at BMI 18 was
performed. The BMI data were grouped into integer values between 18
and 39, and mean pressures and reference intervals were calculated
per unit of BMI. Because of the small number of individuals with BMI
at extreme values, those with BMIs less than 18 and greater than 39
were combined into single groups. The percentage difference was also
calculated between the mean CSFP of each BMI group and the mean
CSFP of those with BMI of 18, as well as the population median BMI of
26. The set of patients who met initial screening was also run against
a filter that identified those who had had an ophthalmic examination
within 1 year of LP. Those with BMI and IOP data were included. If a
repeat ophthalmic examinations was performed, only the IOP mea-
surement closest to the LP data was used. IOPs of the right eye, left eye,
and the average of both eyes were regressed against BMI. A separate
subgroup analysis included patients with recorded height and CSFP.
Patients with height under 121.9 cm (48 in.) were excluded from the
analysis.
Using the least-squares method, we regressed CSFP against BMI for
all subjects and separately by sex. In addition, BMI and sex were both
included in a model with an interaction term to determine whether the
slopes of the men were significantly different from those of the
women. BMI and sex were also used as predictors in a model without
an interaction term. The P values were two-tailed with significance set
at P  0.05.
RESULTS
Between December 1, 1996, and December 31, 2009, 4800
subjects were identified, with height and weight measure-
ments taken on the day an LP was performed and CSFP was
recorded. Of the 4800 subjects, 4235 met all entry criteria. The
majority of the subjects were Caucasian (79.1%) with slightly
more women than men (52.2% vs. 47.8%; Table 1). The mean
age of the study population was 55.0  15.2 years. The mean
CSFP was 10.9  2.8 mm Hg (median, 10.7 mm Hg), with the
women having a slightly lower pressure (mean, 10.5  2.8 mm
Hg; median, 10.3 mm Hg) and the men slightly higher (mean,
11.3  2.8 mm Hg; median, 11.2 mm Hg). The study popula-
tions mean BMI was 26.7  5.3 (median, 26), with the women
slightly lower (mean, 26.0  5.8; median, 25) and the men
slightly higher (mean, 27.4  4.6; median, 27).
The group with BMI of 10 to 17 had a mean CSFP of 9.4 
3.3 mm Hg (n  88), and the group with BMI of 40 to 50 had
an average CSFP of 13.8  2.6 mm Hg (n  74) . Relative to a
BMI of 18, there was a sustained increase in CSFP through BMI
of 39 (37.7%; P  0.001; Table 2; Fig. 1). Univariate least-
TABLE 1. Population Demographics
Age, y












Native American/Eskimo 18 (0.43)
Not Disclosed 16 (0.38)






Not disclosed 10 (0.24)
Total 4235
TABLE 2: Relationship between BMI and CSFP for the Study
Population
BMI CSFP (mm Hg) SD % Increase P n
18 8.79 2.30 * * 94
19 9.42 2.47 6.7 0.046 142
20 8.91 2.56 1.3 0.688 198
21 9.59 2.41 8.3 0.006 216
22 9.68 2.59 9.2 0.002 269
23 9.94 2.62 11.5 0.001 324
24 10.56 2.58 16.8 0.001 358
25 10.34 2.50 15.0 0.001 368
26 10.94 2.58 19.6 0.001 331
27 10.94 2.59 19.7 0.001 313
28 11.58 2.68 24.1 0.001 310
29 11.66 2.59 24.6 0.001 264
30 11.72 2.62 25.0 0.001 240
31 11.93 2.23 26.3 0.001 190
32 12.35 2.44 28.8 0.001 157
33 12.43 2.30 29.3 0.001 113
34 12.95 2.50 32.1 0.001 92
35 12.66 2.65 30.6 0.001 97
36 12.96 2.70 32.2 0.001 77
37 13.42 2.44 34.5 0.001 47
38 13.19 2.34 33.3 0.001 41
39 14.10 2.48 37.7 0.001 27
* Reference point at BMI 18. Italics indicate statistical significance
based on the null hypothesis of the indicated CSFP not differing from
the CSFP for BMI 18.
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squares regression analysis revealed a 0.24-mm Hg increase in
CSFP for every BMI unit (r2  0.20; P  0.001; Fig. 2).
Similar trends were observed between BMI and CSFP
when the analysis was performed according to sex. Relative
to BMI 18, there was a 28.3% increase in mean CSFP (3.82
mm Hg, P  0.002) for the men at BMI 39. For each unit
value increase in BMI, the mean CSFP measurement in-
creased 0.25 mm Hg. The correlation coefficient between
BMI and CSFP was moderate and the slope was significant by
least-squares regression analysis (r2  0.17; P  0.001).
Similarly, in the female subjects, there was a 41.0% increase
in mean CSFP at BMI 39 (5.9 mm Hg; P  0.001) relative to
the pressure at BMI 18. Slope of least-squares regression line
revealed a 0.22-mm Hg increase in mean CSFP per BMI unit
(r2  0.21; P  0.001; Fig. 3).
The mean CSFP was 5.0% higher in the men than in the
women for the BMI range of 18 to 25 (P  0.001). Mean
CSFP was 3.3% higher in the men than in the women in the
BMI 27 to 39 group (P  0.001; Table 3). However, the
results of the tests of interaction of BMI and sex showed that
the difference in the slopes for the men and women was of
borderline significance (P  0.065). Similarly, when the
model contained both BMI and sex without the interaction
term, both were significant, but the r2 (0.21) was no differ-
ent from the r2 of BMI alone (0.20). Including sex did not
improve the fit of the BMI data. Therefore, in this study, the
sex of the individual had little effect in the model of CSFP
and BMI.
Subgroup analysis revealed that height had a statistically
significant, but very small, positive influence on CSFP (r2 
0.02; P  0.001; Fig. 4). There were 474 subjects identified for
IOP and BMI analysis. The mean IOP was 14.9  4.0 mm Hg
(median, 15). Subgroup analysis of IOP and BMI revealed no
relationship between the two variables, and r2  0.004, 0.005,
and 0.005 for the right eye, left eye, and average eye IOP versus
BMI, respectively (Fig. 5).
FIGURE 1. Graph of mean CSFP and
BMI of all subjects in the study pop-
ulation between BMI of 18 and 39.
Error bars, SD.
FIGURE 2. Regression plot of all
CSFP versus BMI data. The formula for
the regression line is y  0.2401x 
4.4503 (r2  0.20; P  0.001).
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DISCUSSION
The findings in this study indicate a direct, linear relationship
between CSFP and BMI, whereas IOP was unaffected by BMI
and CSFP. The results confirm those in previous studies in
which there was a positive correlation between CSFP and
BMI.12,13 Ren et al.12 recently performed a CSFP to BMI anal-
ysis on a small cohort and found a significant correlation
between body weight and CSFP (r2  0.20; P  0.001) as well
as BMI and CSFP (r2  0.25; P  0.001). Several studies have
found no meaningful correlation between initial pressure and
BMI.15–17 In one study of CSFP and BMI in subjects with normal
magnetic resonance venography, no correlation was found
between the two variables.18 These studies were hindered by
small datasets (100–242 subjects) that may have limited the
ability to detect a relationship. In contrast, our much larger
dataset provided stronger evidence of a linear relationship
between CSFP and BMI.
Recent studies have independently found that increasing
BMI is protective for POAG in women; it is noteworthy that the
effect has not been seen in men.10,11 In another study compar-
ing patients with NTG with those with high-tension glaucoma,
Asrani et al.8 found that lower BMI was significantly more
common in the NTG group in both men and women. Even
more interesting is that many studies have identified a direct
correlation between body weight and intraocular pres-
sure.18–22 On the other hand, since IOP does not appear to be
influenced by either BMI or CSFP, these data suggest that,
assuming constant IOP, the translaminar pressure decreases
with increasing BMI and should decrease the risk for glauco-
matous optic nerve damage.
On the basis of findings in retrospective and prospective
studies, there is a growing body of evidence that supports the
notion that CSFP influences risk for POAG. These studies sug-
gest that lower CSFP increases risk for POAG and NTG. Fur-
ther, there is evidence in these studies to suggest that higher
CSFP reduces the risk for glaucoma in patients with ocular
hypertension.1–4 Extrapolation of results obtained from this
study offers a partial explanation of how BMI, through its effect
on CSFP, could influence the risk for glaucoma. These data
suggest that individuals with lower BMIs, particularly at the
extremes, may be at greater risk for glaucoma from the asso-
ciated lower CSFP, and the converse would be true of those
with higher BMIs. We found that CSFPs were nearly the same
in the men and women. Therefore, the CSFP and BMI model,
based on the current data, does not explain the effect of sex.
There must be many factors other than CSFP that are associated
with BMI and independently contribute to the risk for glau-
coma.
Other population-based studies have examined BMI and
POAG, and their results have been conflicting. In a study
focusing on metabolic syndrome and its association with glau-
coma, Newman-Casey et al.5 analyzed different components of
the metabolic syndrome separately and found that, in a mostly
white population, obesity was associated with a greater risk of
developing OAG.5 However, the role of metabolic syndrome in
CSFP, as well as its role as an independent risk factor in
glaucoma, is not known. Of note, multivariate analysis revealed
that the increased hazard ratio applied only to women, not to
men.
The race of the subjects used for this analysis was predom-
inately Caucasian, which is a direct reflection of the surround-
ing referral population. Therefore, it is not known what role
race may have played in the results. For example, in a sample
from Barbados where the population is largely of West African
ancestry, Leske et al.9 found that decreased BMI was associated
with increased prevalence of glaucoma. However, Suzuki et
al.6,7 found no relationship between BMI in Japanese POAG
patients and controls in the Tajimi Study. It is worth noting that
the range of BMI in the Japanese population is lower than that
in the United States population. In fact, the World Health
Organization reported that more than two thirds of adult Jap-
anese have a normal BMI (18.5–24.99) compared with the
adults in the United States, where 36% have a normal BMI.23 It
is also interesting that 90% of Japanese had normal screening
IOP in the Tajimi Study, whereas approximately two thirds had
elevated IOP in the Baltimore Eye Survey.6,7,24 How population
and environmental characteristics influence the relationship
between BMI and other factors affect CSFP remains to be
explored.









BMI 18–25 9.8  2.5 10.1  2.7 9.6  2.4 5.0, P  0.0001
BMI 27–39 11.9  2.6 12.1  2.5 11.7  2.7 3.3, P  0.0001
The percentage difference between the male and female groups is included in the last column.
Significance is based on the null hypothesis that the mean male CSFP will not differ from the mean female
CSFP.
FIGURE 3. Chart of CSFP and BMI
comparing the variables by sex. Error
bars, SD.
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One of the main limitations of this study is that it was
retrospective. Study subjects were selected on the basis of
information available within the database and restricted to
patients who presumably did not have conditions that influ-
ence the values studied. It is likely that patients were included
that should have been excluded. However, the number of such
patients is unlikely to be sufficient to alter the findings of the
analysis. It is also important to note that this study compared
the means of each BMI group. CSFP, like IOP or blood pres-
sure, has a wide range of statistically normal values. For this
reason, the definition of a normal range is arbitrary and pre-
vents useful interpretation of individual values. By design, this
study was a composite of individual LP measurements per-
formed at a specific time point. Therefore, it was cross-sec-
tional, and the data cannot be used to interpret changes in BMI
or CSFP that occur as a function of time. Although these are
important considerations, we conclude that the impact on this
study, derived from such a large dataset, is small.
We initially collected all blood pressure (BP) and IOP data
that were measured within 1 month of an LP. Ideally, we
would have both the IOP and BP at the time of LP. We know
that BP affects CSFP, and IOP does not.25–27 Further, there are
far fewer factors that affect IOP compared with blood pressure.
Our inability to control for these factors is a limitation, but the
variable is likely to be stable enough to permit a useful analysis.
On the other hand, BP directly affects CSFP and there are
multiple factors that affect BP. The relationship should be
studied only if both measures were performed simultaneously.
For this reason, we have elected not to analyze the relationship
between BP and CSFP in this study.
Another unknown is the relationship between intracranial
pressure in the upright position and that in the lateral decub-
itus position, where it is measured. CSF is a fluid column within
the spinal canal and is in direct communication with the
ventricles. It is known that CSFP changes as a function of
orientation.28,29 For example, in the seated position, the CSFP
is 0, typically at a point located between the intracranial area
and the upper thoracic region. The pressures above this loca-
tion are negative. The biomechanical effects of this phenom-
enon as it pertains to the translaminar pressure are an impor-
tant area for future research.
In conclusion, we observed a positive, linear relationship
between mean CSFP and BMI in a large sample. Patients with
higher BMI had, on average, higher CSFP than did those with
FIGURE 4. Relationship between
CSFP and height (r2  0.02, P 
0.001).
FIGURE 5. Individuals’ average IOPs
plotted against BMI (r2  0.005; P 
0.001).
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lower BMI. BMI did not affect the IOP in the subgroup of
patients who were analyzed. Therefore, in the scope of this
large population, there is a trend of increasing mean CSFP with
increasing BMI and stable mean IOP with increasing BMI. The
result suggests that the translaminar pressure difference de-
clines with an increase in BMI. As a large translaminar pressure
difference has been observed in patients with POAG and a low
translaminar pressure difference is associated with ocular hy-
pertension, these findings provide supporting evidence that
increased BMI correlates with increased CSFP, which, in turn,
may be protective against glaucoma. This is an important find-
ing that helps to support the fact that not all patients with a
high IOP have glaucoma and that many patients with glaucoma
have a normal IOP—further evidence that attention should be
focused on the translaminar pressure difference.
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